Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.45 |
| ▸ | CNR2 | P34972 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CNR1 | P21554 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9618633 | 0.93 | ALDH1A1 (0.47) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| SCHEMBL3526348 | 0.89 | ALDH1A1 (0.44) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Allylbenzene SCHEMBL27688145 | 0.88 | MAOB (0.48) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| SCHEMBL9501888 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| SCHEMBL173301 | 0.86 | ALDH1A1 (0.64) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Phosphine SCHEMBL28908227 | 0.83 | ALDH1A1 (0.61) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Water SCHEMBL29179560 | 0.83 | ALDH1A1 (0.61) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Bromide SCHEMBL8645583 | 0.83 | ALDH1A1 (0.61) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Allylbenzene SCHEMBL28026512 | 0.82 | ALDH1A1 (0.45) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 | |
| Hydrogen Peroxide SCHEMBL5496256 | 0.80 | ALDH1A1 (0.58) | ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983418-B1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-113939522-B | Organosilane, ionic organosilane, film composition and film | 3M创新有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-12122797-B2 | Organosilane, ionic organosilane, membrane composition, and membrane | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-10-22 | — | — | US | disclosed |
| US-20240052109-A1 | POLYSILOXANE VINYLIC MONOMERS AND USES THEREOF | ALCON INC. (CH) | 2024-02-15 | — | — | US | disclosed |
| US-20230265235-A1 | CURABLE POLYFARNESENE-BASED COMPOSITIONS | FINA TECHNOLOGY, INC. (US) | 2023-08-24 | — | — | US | disclosed |
| US-11634531-B2 | Curable polyfarnesene-based compositions | FINA TECHNOLOGY, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-20220251120-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | US DEPARTMENT OF ENERGY | 2022-08-11 | — | — | US | disclosed |
| EP-3983418-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M Innovative Properties Company (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-113939522-A | Organosilane, ionic organosilane, film composition and film | 3M创新有限公司 | 2022-01-14 | — | — | CN | disclosed |
| WO-2020254930-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-12-24 | — | — | WO | disclosed |
| EP-0415404-A2 | Process for producing unsaturated group-terminated high-molecular weight polyalkylene oxide | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0212838-B1 | OPTICALLY ACTIVE LIQUID CRYSTAL COMPOUND HAVING METHYLENEOXY GROUP AND COMPOSITION CONTAINING SAME | Chisso Corporation (JP) | 1990-10-03 | — | — | EP | disclosed |
| EP-0312967-A1 | Sealant for double-layered glass | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4729847-A | LIGHT SWITCHING ELEMENT | CHISSO CORPORATION (JP) | 1988-03-08 | — | — | US | disclosed |
| EP-0212838-A1 | Optically active liquid crystal compound having methyleneoxy group and composition containing same | Chisso Corporation (JP) | 1987-03-04 | — | — | EP | disclosed |
| EP-0058512-B1 | LIQUID CRYSTAL COMPOUNDS EXHIBITING A SMALL DIELECTRIC ANISOTROPY AND LIQUID CRYSTAL MATERIALS AND DEVICES INCORPORATING SUCH COMPOUNDS | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1986-01-15 | — | — | EP | disclosed |
| US-4556745-A | BICYCOL(2.2.2) OCATANE RING | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1985-12-03 | — | — | US | disclosed |
| EP-0058512-A1 | Liquid crystal compounds exhibiting a small dielectric anisotropy and liquid crystal materials and devices incorporating such compounds | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1982-08-25 | — | — | EP | disclosed |
| US-3974220-A | POLYOXYALKYLENE ETHERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | disclosed |
| US-3971751-A | ROOM TEMPERATURE | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251120-A1 | ORGANOSILANE, IONIC ORGANOSILANE, MEMBRANE COMPOSITION, AND MEMBRANE | PHOSPHO1, ARRB1, OR51E2 | ALDH1A1 3218/4885CYP3A4 2878/4885SMN1; SMN2 3269/4885 |
| US-12122797-B2 | Organosilane, ionic organosilane, membrane composition, and membrane | PHOSPHO1, ARRB1, OR51E2 | ALDH1A1 3218/4885CYP3A4 2878/4885SMN1; SMN2 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.